Guide-yakabatana mibvunzo · Pakati Nhanho
AI muClinical Trials Quiz
Ongorora kuti AI inotsigira sei kuenzanirana kwemurwere, dhizaini yekuyedza, zvidzidzo zvinochinjika, kutarisa kwekuchengetedza, uye kusimbiswa kwemutemo mukutsvagisa kwekiriniki.
Mubvunzo 1 ye 8
Nderipi dambudziko renguva refu mumakiriniki ekuedzwa rinonyanya kunanga neAI?
Tarisa mubvunzo wese8 mibvunzo
Mhinduro uye tsananguro zvinoonekwa paunenge uchitora bvunzo.
- Nderipi dambudziko renguva refu mumakiriniki ekuedzwa rinonyanya kunanga neAI?
- Kunonoka uye kwakaoma kutora varwere
- Ruvara rwemishonga yekuputira
- Mamenu ekudyira kuchipatara
- Kuwanika kwekupaka panzvimbo dzekuyedza
- How can natural-language processing help screen patients for clinical trials?
- Nekudarika kuongororwa kwekuchengetedza
- Extract clinical information from electronic health records and compare it with trial eligibility criteria
- Nokubhadhara varwere kupfuura vakwikwidzi
- Nekupfupisa kutongwa kusvika kune rimwe zuva
- What is an external control arm in a clinical trial?
- Robhoti prosthetic nhengo
- Mushonga unogadzirwa nekombiyuta
- A comparison group drawn from data outside the trial, such as historical or concurrent external data
- A backup data server
- What can propensity-score matching do when constructing an external-control comparison?
- Kuronga nearufabheti
- Random nhamba yechizvarwa chete
- Kuongorora zviperengo
- Balance measured baseline covariates related to treatment assignment
- Sei fungidziro yekudonha uye saiti-kuita modhi zvine basa kune vanotsigira miedzo?
- Vanorega vatsigiri vapindira pamberi pematare edzimhosva
- Ivo vanogadzira chivakwa chekuvaka
- Vanonyora masirogani ekutengesa
- Vanosarudza yunifomu yevashandi
- What does FDA’s January 2025 draft AI guidance address for drugs and biologics?
- Kuderedza tsvakurudzo yose zvachose
- AI used to generate information supporting regulatory decisions about safety, effectiveness, or quality
- Nekuti AI haisi pamutemo mukurapa
- Kuderedza nhamba yevanachiremba
- What can a Bayesian adaptive clinical-trial design change as evidence accumulates?
- The original trial question after results are known
- The identity of past participants
- Trial elements such as dosing or allocation to study arms under prespecified rules
- The inclusion criteria without documentation
- Which pharmacovigilance tasks does FDA identify as possible uses for emerging AI?
- Only advertising click-through rates
- Satellite images of clinical sites
- Unrelated social-media sentiment about packaging
- Adverse-event intake, data entry, processing, and safety-signal detection or evaluation